| | | | Todd Magro, MD | | | | SPEAKER BIO | | | | Dr. Magro is a 4th year resident in the General Psychiatry Program at MUSC and a 2nd year resident in the NIDA-funded Drug and Alcohol Research Tract. He received his medical degree from the University of Tennessee. His research interests include substance abuse. Currently, he is researching outcomes of Veterans Administrations patients who have been treated with long-acting naltrexone for alcohol dependence. He is also involved in a treatment study investigating the efficacy of providing biomarker feedback in treating alcohol dependence. Dr. Magro is mentored in the DART program by Dr. Raymond Anton and Dr. Tara Wright. He will begin an Addictions Psychiatry fellowship at MUSC in July. | | | | | OBJECTIVES | | | | | At the completion of this session, the participant will be able to: | | | 1. Describe the mechanism of action for naltrexone used in the treatment of alcohol dependence.
2. List advantages and disadvantages of oral and long-acting injectable naltrexone for treatment of alcohol dependence.
3. Understand the efficacy of naltrexone for treating alcohol dependence and which patients may benefit the most from naltrexone. | | | | |
| | | |
|
| |
